Show simple item record

dc.contributor.authorFernández Romero, Lucía
dc.contributor.authorDíez-Cirarda, María
dc.contributor.authorDelgado Alonso, Cristina
dc.contributor.authorCabrera Martin, Maria Nieves
dc.contributor.authorGonzález Rosa, Javier Jesús 
dc.contributor.authorSanz Nieto, Carmen
dc.contributor.authorPérez-Macías, Natalia
dc.contributor.authorBalugo, Paloma
dc.contributor.authorGomez-Ruiz, Natividad
dc.contributor.authorMatias-Guiu, Jorge
dc.contributor.authorPortolés Pérez, Antonio
dc.contributor.authorMatias-Guiu, Jordi
dc.contributor.otherPsicologíaes_ES
dc.date.accessioned2026-10-19T07:08:21Z
dc.date.available2026-10-19T07:08:21Z
dc.date.issued2026-05-20
dc.identifier.issn2044-6055
dc.identifier.urihttp://hdl.handle.net/10498/40392
dc.description.abstractIntroduction: Primary progressive aphasia (PPA) is a neurodegenerative syndrome associated with Alzheimer's disease and frontotemporal degeneration. Non-invasive brain stimulation (NIBS) is a promising treatment, especially associated with language therapy, but comparative efficacy and long-term effects between the different techniques (transcranial direct current stimulation (tDCS) and transcranial magnetic stimulation (TMS)) remain unknown. The present study aims to investigate the effects of non-invasive brain stimulation, alone or associated (tDCS/TMS/tDCS plus TMS) combined with language therapy delivered during a period of 6 months, in the progression of language impairment in PPA, compared with sham stimulation combined with language therapy. Methods and analysis: The study is a randomised, double-blinded, parallel, sham-controlled clinical trial. Patients with PPA in early stages (global Clinical Dementia Rating equal to or less than 1) are eligible. They are to be randomised to one of the four treatment arms of the study (active tDCS-active TMS, active tDCS-sham TMS, sham tDCS-active TMS, sham tDCS-sham TMS). All patients will receive language therapy immediately after each session of NIBS, for 6 months. The primary outcome is the Mini-Linguistic State Examination. The secondary outcomes are naming of trained items, Addenbrooke's Cognitive Examination, Interview for Deterioration in Daily Living Activities, Clinical Dementia Rating including behaviour and language domains, Neuropsychiatric Inventory and regional brain metabolism. Exploratory substudies will be conducted including blood biomarkers, quantitative electroencephalography and spontaneous speech assessment. Ethics and dissemination: The study is registered (ClinicalTrials.gov: NCT07158216) and approved by the Ethics Committee of the Hospital Clinico San Carlos (code 25/309-IC_P_CE). Patients will be enrolled after signing an informed consent form. Study outcomes will be disseminated through presentations at scientific conferences, publications in peer-reviewed journals and other academic forums. Trial registration number: NCT07158216.es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherBMJ Publishing Groupes_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceBMJ Open - 2026, Vol. 16, n. 5, e112999es_ES
dc.titleLong-term effect of transcranial magnetic stimulation and transcranial electrical stimulation in primary progressive aphasia: study protocol for a randomised, double-blind clinical trial (RECONNECT-PLUS).es_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1136/bmjopen-2025-112999
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This work is under a Creative Commons License Attribution-NonCommercial-NoDerivatives 4.0 Internacional